CSS
NVS icon

Cubist Systematic Strategies’s Novartis NVS Stock Holding History

Cubist Systematic Strategies’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,600
Closed -$263K – 4119
2023
Q4 		$263K Hold
2,600
– – ﹤0.01% 2848
2023
Q3 		$265K Buy
+2,600
New +$264K ﹤0.01% 2652
2023
Q2 		– Sell
-52,800
Closed -$4.86M – 4055
2023
Q1 		$4.86M Sell
52,800
-60,500
-53% -$5.28M 0.03% 954
2022
Q4 		$10.3M Buy
113,300
+68,200
+151% +$5.74M 0.06% 461
2022
Q3 		$3.43M Buy
45,100
+40,100
+802% +$3.32M 0.02% 1442
2022
Q2 		$423K Buy
+5,000
New +$439K ﹤0.01% 3183

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cubist Systematic Strategies's NVS Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Novartis (NVS) in Q1 2025, closing a stake of 56,891 shares — an estimated $5.54M sold.

Cubist Systematic Strategies first reported a position in NVS in Q2 2014 and held it in 40 quarters. The position peaked at $13.8M in Q1 2024. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 56,891 Novartis shares in Q1 2025, an estimated $5.54M.
  • Cubist Systematic Strategies first reported a position in Novartis in Q2 2014 and held it in 40 quarters.
  • Cubist Systematic Strategies's Novartis position peaked at $13.8M in Q1 2024.
  • 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.